Market Place
Sourcing Support
Medigene Files Patent for Unique NK-Specific TCR with EPO
13 Mar 2025 //
GLOBENEWSWIRE
Medigene Expands U.S. Patent Portfolio With JOVI Technology Grant
19 Feb 2025 //
GLOBENEWSWIRE
Cash-strapped Medigene lays off 40%, pauses plan to enter clinic
26 Nov 2024 //
FIERCE BIOTECH
Medigene Presents KRAS Library And UniTope & TraCR Tech At ESMO 2024
14 Sep 2024 //
GLOBENEWSWIRE
Medigene Secures Two Additional Patents for Its End-to-End Technology Platform
29 Aug 2024 //
GLOBENEWSWIRE
Medigene to Present at Upcoming Investor Conferences
28 Aug 2024 //
GLOBENEWSWIRE
Medigene Reports H1 2024 Financial Results And Corporate Update
14 Aug 2024 //
GLOBENEWSWIRE
Medigene AG to Report Half-Year 2024 Financial Results on August 14, 2024
08 Aug 2024 //
GLOBENEWSWIRE
Medigene to Present at ESMO Congress 2024
23 Jul 2024 //
GLOBENEWSWIRE
Medigene Granted Chinese Patent For NY-ESO-1/LAGE 1a T Cell Receptor
03 Jul 2024 //
GLOBENEWSWIRE
Medigene Reports Results of Annual General Meeting
24 Jun 2024 //
GLOBENEWSWIRE
Medigene to Present at Cell and Gene Therapy Summit 2024
21 Jun 2024 //
GLOBENEWSWIRE
Medigene AG Announces Lead Selection For MDG2021, Expanding TCR-T KRAS Library
20 Jun 2024 //
GLOBENEWSWIRE
Medigene Expands its End-to-End Platform by Submitting Three Patents to the EPO
28 May 2024 //
PHARMIWEB
Medigene: Three Patent Filings For Optimization Tech Platform
28 May 2024 //
GLOBENEWSWIRE
Medigene Presents Data On Optimal TCRs Targeting Mutant KRAS Neoantigen
15 May 2024 //
GLOBENEWSWIRE
Medigene Extends Cash Runway To July 2025 After Successful Raise
14 May 2024 //
GLOBENEWSWIRE
Medigene to Present at Upcoming Conferences
07 May 2024 //
GLOBENEWSWIRE
Medigene Presents Superior TCR-T Cell Data With Costimulatory Switch
02 May 2024 //
GLOBENEWSWIRE
Medigene Expands Patent Portfolio With European NY-ESO-1 TCR Grant
02 May 2024 //
GLOBENEWSWIRE
Medigene AG reports Financial Results and Business Update for Q1 2024
26 Apr 2024 //
GLOBENEWSWIRE
Medigene Presents 6-Day High Stemness TCR-T Production
25 Apr 2024 //
GLOBENEWSWIRE
Medigene to Present at Upcoming Scientific Conferences
17 Apr 2024 //
GLOBENEWSWIRE
Medigene Presents Favorable Safety Profile of TCR-T Cells at AACR
08 Apr 2024 //
GLOBENEWSWIRE
Medigene AG Secures European Patent for its iM-TCR Technology
04 Apr 2024 //
GLOBENEWSWIRE
Medigene AG Reports Full-Year 2023 Financial Results
28 Mar 2024 //
GLOBENEWSWIRE
Medigene to participate in the H.C. Wainwright Virtual Conference
19 Mar 2024 //
GLOBENEWSWIRE
Medigene AG to report full year 2023 financial results on March 28, 2024
18 Mar 2024 //
GLOBENEWSWIRE
Medigene to Present Favorable Safety Profile of TCR-T Cells
06 Mar 2024 //
GLOBENEWSWIRE
Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology
04 Mar 2024 //
GLOBENEWSWIRE
Medigene Presents for Development of Differentiated TCR-T Therapies
29 Feb 2024 //
GLOBENEWSWIRE
Medigene to Present at Upcoming Conferences
19 Feb 2024 //
GLOBENEWSWIRE
Medigene amends 2023 financial guidance
21 Nov 2023 //
GLOBENEWSWIRE
Medigene AG Announces Prioritization of Pipeline
21 Nov 2023 //
GLOBENEWSWIRE
Medigene Reports Financial Results and Corporate Update for Q3 2023
26 Oct 2023 //
GLOBENEWSWIRE
Medigene presents first data of optimal affinity TCR targeting mKRAS G12V
23 Oct 2023 //
GLOBENEWSWIRE
Medigene to present data for pipeline TCR-T therapies at the ESMO Congress 2023
16 Oct 2023 //
GLOBENEWSWIRE
Medigene Secures European Patent for its PD1-41BB Costimulatory Switch Protein
27 Sep 2023 //
GLOBENEWSWIRE
Medigene AG to present at the Baader Investment Conference 2023
11 Sep 2023 //
GLOBENEWSWIRE
Medigene AG to present at the H.C. Wainwright 25th Annual Global Conference
05 Sep 2023 //
GLOBENEWSWIRE
Medigene presents rationale for combining its 3S TCRs with enhancement tools
30 Aug 2023 //
GLOBENEWSWIRE
Medigene Expands Intellectual Property Rights for Costimulatory Switch Proteins
23 Aug 2023 //
GLOBENEWSWIRE
Medigene AG to present at the 8th CAR-TCR Summit in Boston
22 Aug 2023 //
GLOBENEWSWIRE
Medigene AG Reports Second Quarter and Six Months 2023 Financial Results
17 Aug 2023 //
GLOBENEWSWIRE
Medigene to participate in H.C. Wainwright Immune Cell Engager Conference
16 Aug 2023 //
GLOBENEWSWIRE
Medigene AG to report Second Quarter and Six Months 2023 Financial Results
10 Aug 2023 //
GLOBENEWSWIRE
Medigene Presents Enhanced Tumor Cell Killing Effects upon Addition of PD1-41BB
22 Jun 2023 //
GLOBENEWSWIRE
Medigene to Host Virtual R&D Event on TCR-T Therapies for Solid Tumors
13 Jun 2023 //
GLOBENEWSWIRE
Medigene Announces Pipeline Expansion into Neoantigens
01 Jun 2023 //
GLOBENEWSWIRE
Medigene AG to participate at BIO International in Boston
30 May 2023 //
GLOBENEWSWIRE
Medigene AG Expands Patent Portfolio for its End-to-End Platform
22 May 2023 //
GLOBENEWSWIRE
Medigene AG to present at upcoming investor conferences
08 May 2023 //
GLOBENEWSWIRE
Expitope 3.0 presented at CIMT enables more comprehensive analysis of target
04 May 2023 //
GLOBENEWSWIRE
Medigene AG reports financial results and business update for Q1 2023
03 May 2023 //
GLOBENEWSWIRE
Medigene expands end-to-end technology platform through licence, of a CD40L-CD28
02 May 2023 //
GLOBENEWSWIRE
Medigene AG to Present Expitope 3.0 at the 20th (CIMT)
27 Apr 2023 //
GLOBENEWSWIRE
New data presented at AACR Annual Meeting demonstrates anti-solid tumor
18 Apr 2023 //
GLOBENEWSWIRE
Medigene Presents End-To-End Platform Approach to Optimize TCR-T Development
04 Apr 2023 //
GLOBENEWSWIRE
Medigene enters R&D Agreement with the National Cancer Institute
03 Apr 2023 //
GLOBENEWSWIRE
